2022
DOI: 10.1080/15384101.2022.2119514
|View full text |Cite
|
Sign up to set email alerts
|

Upregulated miR-194-5p suppresses retinal microvascular endothelial cell dysfunction and mitigates the symptoms of hypertensive retinopathy in mice by targeting SOX17 and VEGF signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 64 publications
0
2
0
Order By: Relevance
“…For instance, the dysregulation of miR-637 has been reported to be implicated in the progression of retinopathy in patients with hypertension and regulate retinol endothelial cell proliferation [26]. In addition, upregulated miR-194-5p has been reported to suppress the dysfunctions of retinal microvascular endothelial cells and mitigate hypertensive retinopathy symptoms in mice via binding to SOX17 and VEGF pathways [9]. Herein, the expression levels of several miRNAs showed to be signi cantly changed within the hypertensive retinopathy model than normal control, as well as in the treatment group compared with the model group, further evidencing that miRNAs might contribute to hypertensive retinopathy development and could potentially act as therapeutic targets.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For instance, the dysregulation of miR-637 has been reported to be implicated in the progression of retinopathy in patients with hypertension and regulate retinol endothelial cell proliferation [26]. In addition, upregulated miR-194-5p has been reported to suppress the dysfunctions of retinal microvascular endothelial cells and mitigate hypertensive retinopathy symptoms in mice via binding to SOX17 and VEGF pathways [9]. Herein, the expression levels of several miRNAs showed to be signi cantly changed within the hypertensive retinopathy model than normal control, as well as in the treatment group compared with the model group, further evidencing that miRNAs might contribute to hypertensive retinopathy development and could potentially act as therapeutic targets.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have highlighted the importance of ncRNAs in hypertensive retinopathy. For instance, miRNAs, which are small ncRNAs that bind to the 3' untranslated region of target mRNAs to modulate gene expression, could regulate endothelial function, in ammation, and vascular remodeling in hypertensive retinopathy [7][8][9]. Similarly, lncRNAs that are longer than 200 nucleotides and could modulate gene expression through various mechanisms, have been shown to be differentially expressed within the retinas of hypertensive rats and may contribute to the pathogenesis of hypertensive retinopathy [10,11].…”
mentioning
confidence: 99%